GSK exec accused of bribery

Share this article:

The former head of GlaxoSmithKline's China division has been accused of bribery. Bloomberg reports that Mark Reilly has been accused of ordering employees to bribe doctors, hospitals and medical groups to boost drug sales.

GSK told Bloomberg that they cooperating with authorities. The drugmaker noted earlier this year that corruption allegations have inflicted damage on regional sales.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.